$EBON
Ebang International Holdings Inc. Stock $ebon

$ebon Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024036625 Filed on April 26, 2024

Income Statement

Concept	2023	2022 Q4
Revenue	$4.855M	$7.270M
YoY Change	-84.98%
Cost Of Revenue	$21.56M	$6.100M
YoY Change	27.45%	-91.71%
Gross Profit	-$16.70M	$1.170M
YoY Change	-208.38%
Gross Profit Margin	-344.04%	16.09%
Selling, General & Admin	$30.94M	$18.08M
YoY Change	-51.21%
% of Gross Profit		1545.3%
Research & Development	$7.401M
YoY Change	43.79%
% of Gross Profit
Depreciation & Amortization	$3.520M
YoY Change	93.09%
% of Gross Profit
Operating Expenses	$36.94M	$18.08M
YoY Change	-41.74%
Operating Profit	-$53.64M	-$16.91M
YoY Change	11.78%
Interest Expense		$2.460M
YoY Change
% of Operating Profit
Other Income/Expense, Net	$14.57M	$280.0K
YoY Change	575.31%
Pretax Income	-$39.07M	-$34.90M
YoY Change	-14.71%
Income Tax	-$1.031M	-$60.00K
% Of Pretax Income
Net Earnings	-$36.77M	-$33.81M
YoY Change	-19.64%
Net Earnings / Revenue	-757.38%	-465.06%
Basic Earnings Per Share	-$5.86
Diluted Earnings Per Share	-$5.86	-$5.53
COMMON SHARES
Basic Shares Outstanding	6.275M shares
Diluted Shares Outstanding	6.275M shares

Balance Sheet

Concept	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$256.9M
YoY Change		6.61%
Cash & Equivalents	$241.6M	$251.3M
Short-Term Investments		$5.612M
Other Short-Term Assets	$5.692M	$6.711M
YoY Change	-15.19%	34.38%
Inventory	$198.8K	$440.1K
Prepaid Expenses	$304.5K	$281.6K
Receivables	$946.5K	$3.335M
Other Receivables		$0.00
Total Short-Term Assets	$250.4M	$269.1M
YoY Change	-6.94%	-9.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.15M	$36.55M
YoY Change	-9.3%	9.66%
Goodwill		$2.300M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$918.1K	$1.421M
YoY Change	-35.41%	101.37%
Total Long-Term Assets	$47.81M	$75.06M
YoY Change	-36.31%	-13.76%
TOTAL ASSETS
Total Short-Term Assets	$250.4M	$269.1M
Total Long-Term Assets	$47.81M	$75.06M
Total Assets	$298.2M	$344.2M
YoY Change	-13.34%	-10.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$292.6K	$1.457M
YoY Change	-79.91%	-57.01%
Accrued Expenses		$1.500M
YoY Change
Deferred Revenue	$69.36K	$1.011M
YoY Change	-93.14%	1357.38%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.96M	$15.49M
YoY Change	-22.78%	5.32%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$5.800M
YoY Change
Total Long-Term Liabilities	$4.957M	$6.890M
YoY Change	-28.04%	216.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.96M	$15.49M
Total Long-Term Liabilities	$4.957M	$6.890M
Total Liabilities	$16.92M	$22.38M
YoY Change	-24.4%	32.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$114.8M	-$78.07M
YoY Change	47.1%	128.4%
Common Stock		$18.08K
YoY Change		1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$279.8M	$321.8M
YoY Change
Total Liabilities & Shareholders Equity	$298.2M	$344.2M
YoY Change	-13.34%	-10.81%

Cashflow Statement

Concept	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$36.77M	-$33.81M
YoY Change	-19.64%
Depreciation, Depletion And Amortization	$3.520M
YoY Change	93.09%
Cash From Operating Activities	-$11.65M
YoY Change	-371.21%
INVESTING ACTIVITIES
Capital Expenditures	$985.8K
YoY Change	-92.99%
Acquisitions
YoY Change
Other Investing Activities	-$7.524K
YoY Change	-100.04%
Cash From Investing Activities	$2.753M
YoY Change	-58.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	-$11.65M
Cash From Investing Activities	$2.753M
Cash From Financing Activities
Net Change In Cash	-$9.307M
YoY Change	-182.36%
FREE CASH FLOW
Cash From Operating Activities	-$11.65M
Capital Expenditures	$985.8K
Free Cash Flow	-$12.64M
YoY Change	29.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.86
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39337
CY2023	dei	Entity Registrant Name EntityRegistrantName	EBANG INTERNATIONAL HOLDINGS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	12 Marina View
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	#20-02B
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Asia Square Tower 2
CY2023	dei	Entity Address Country EntityAddressCountry	SG
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	018961
CY2023	dei	Security12b Title Security12bTitle	Class A ordinary shares, par value HK$0.03 per share
CY2023	dei	Trading Symbol TradingSymbol	EBON
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	241634262	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	251294952	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	88614	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	29039	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	496122	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	5835377	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	946514	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3334727	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1071137	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1178168	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	198846	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	440064	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	304453	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	281611	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5691679	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6711422	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	250431627	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	269105360	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33151061	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36549278	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2329777	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6890738	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6119535	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5343608	usd
CY2023Q4	ebon	Operating Lease Rightofuse Assets Related Party OperatingLeaseRightofuseAssetsRelatedParty	31197	usd
CY2022Q4	ebon	Operating Lease Rightofuse Assets Related Party OperatingLeaseRightofuseAssetsRelatedParty	519140	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1197286	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	903125	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2299628	usd
CY2023Q4	ebon	Vat Recoverables VATRecoverables	4061079	usd
CY2022Q4	ebon	Vat Recoverables VATRecoverables	21132898	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	918086	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1421309	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	47808021	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	75059724	usd
CY2023Q4	us-gaap	Assets Assets	298239648	usd
CY2022Q4	us-gaap	Assets Assets	344165084	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	292570	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1456577	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9804848	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11519091	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1764259	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1217604	usd
CY2023Q4	ebon	Operating Lease Liabilities Related Party Current OperatingLeaseLiabilitiesRelatedPartyCurrent	28849	usd
CY2022Q4	ebon	Operating Lease Liabilities Related Party Current OperatingLeaseLiabilitiesRelatedPartyCurrent	283567	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	69361	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1010852	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11959887	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15487691	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4880844	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5755973	usd
CY2023Q4	ebon	Operating Lease Liabilities Related Party Noncurrent OperatingLeaseLiabilitiesRelatedPartyNoncurrent	2348	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	74225	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1133539	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4957417	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6889512	usd
CY2023Q4	us-gaap	Liabilities Liabilities	16917304	usd
CY2022Q4	us-gaap	Liabilities Liabilities	22377203	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	397467795	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	397620927	usd
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	11079649	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	11079649	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114840665	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78068522	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13887088	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11724531	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	279843847	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	318931581	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1478497	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2856300	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	281322344	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321787881	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	298239648	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	344165084	usd
CY2023	us-gaap	Revenues Revenues	4855181	usd
CY2022	us-gaap	Revenues Revenues	32328119	usd
CY2021	us-gaap	Revenues Revenues	51450247	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	21558986	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	16915795	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	22227055	usd
CY2023	us-gaap	Gross Profit GrossProfit	-16703805	usd
CY2022	us-gaap	Gross Profit GrossProfit	15412324	usd
CY2021	us-gaap	Gross Profit GrossProfit	29223192	usd
CY2023	us-gaap	Selling Expense SellingExpense	1893607	usd
CY2022	us-gaap	Selling Expense SellingExpense	1956120	usd
CY2021	us-gaap	Selling Expense SellingExpense	1418586	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29041432	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40712314	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25774237	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3708247	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	20738130	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2299628	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	36942914	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	63406564	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	27192823	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	7524	usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	5941	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-53639195	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-47988299	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2030369	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	11941453	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	4362832	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	1779672	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	4383	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1131178	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1033622	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	133477	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	356996	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-509496	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3656520	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	744803	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	456647	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2161264	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1780087	usd
CY2023	ebon	Income Tax Expense Benefit Continuing Operation Government Grants IncomeTaxExpenseBenefitContinuingOperationGovernmentGrants	62600	usd
CY2022	ebon	Income Tax Expense Benefit Continuing Operation Government Grants IncomeTaxExpenseBenefitContinuingOperationGovernmentGrants	81911	usd
CY2021	ebon	Income Tax Expense Benefit Continuing Operation Government Grants IncomeTaxExpenseBenefitContinuingOperationGovernmentGrants	434604	usd
CY2023	us-gaap	Other Expenses OtherExpenses	119531	usd
CY2022	us-gaap	Other Expenses OtherExpenses	649476	usd
CY2021	us-gaap	Other Expenses OtherExpenses	108328	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14574146	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2158129	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	358609	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39065049	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45830170	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2388978	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1031461	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-72933	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-378843	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-38033588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-45757237	usd
CY2021	us-gaap	Profit Loss ProfitLoss	2767821	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1261445	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1868995	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1663120	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-36772143	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43888242	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4430941	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-38033588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-45757237	usd
CY2021	us-gaap	Profit Loss ProfitLoss	2767821	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2278915	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5338217	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	953073	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-40312503	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-51095454	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3720894	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1377803	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2379686	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1461374	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38934700	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48715768	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5182268	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.86
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.86
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6275118	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6247333	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5923845	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6275118	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6247333	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5928858	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	109823766	usd
CY2021	ebon	Share Issuance Following Initial Public Offering Net Of Issuance Cost ShareIssuanceFollowingInitialPublicOfferingNetOfIssuanceCost	186776725	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	67950980	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	707000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	2767821	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-953073	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	368979365	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3903970	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-45757237	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5338217	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321787881	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-153034	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-38033588	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2278915	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	281322344	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-38033588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-45757237	usd
CY2021	us-gaap	Profit Loss ProfitLoss	2767821	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3519859	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10711543	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6258055	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	975114	usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	-310012	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	3803437	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	559817	usd
CY2021	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-1100792	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	-153034	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3903970	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	707000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-478849	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-547338	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9243	usd
CY2023	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-200000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	340186	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	6482019	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	2233452	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	356996	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-509496	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-3656520	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2299628	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1031461	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-80599	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2845588	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	57117	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3109922	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3708247	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	20738130	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	16688647	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	4474784	usd
CY2023	ebon	Loss From Cybersecurity Incidence LossFromCybersecurityIncidence	-2251551	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1835542	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1711943	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1066838	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	456647	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2161264	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	1780087	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	744803	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	7524	usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	5941	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2612509	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2882106	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-333888	usd
CY2021	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-775206	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	122326	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	185504	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5392810	usd
CY2023	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	-106246	usd
CY2022	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	178639	usd
CY2021	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	818666	usd
CY2023	ebon	Increase Decrease In Vat Recoverables IncreaseDecreaseInVATRecoverables	133790	usd
CY2022	ebon	Increase Decrease In Vat Recoverables IncreaseDecreaseInVATRecoverables	1247508	usd
CY2021	ebon	Increase Decrease In Vat Recoverables IncreaseDecreaseInVATRecoverables	3799426	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-956970	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-10410167	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2951664	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	323279	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	850791	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	51928	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1130842	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1787125	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	705	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-916451	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	163883	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	51792	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-4272841	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-14109951	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-18329126	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11653117	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4296785	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15849840	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	985794	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3803943	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6153759	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10260785	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2365495	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	28552566	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	472357646	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	5694982	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	55101678	usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	474365880	usd
CY2023	ebon	Purchase Of Cryptocurrencies PurchaseOfCryptocurrencies	9162886	usd
CY2023	ebon	Proceeds From Disposal Of Cryptocurrencies ProceedsFromDisposalOfCryptocurrencies	-7199398	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5863499	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-7524	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	11492	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2753224	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6609393	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6511020	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	771629	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5671902	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	254727705	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248284174	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-407061	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	394336	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	879537	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9306954	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11300514	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	226802851	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	252227116	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	240926602	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14123751	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242920162	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	252227116	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	240926602	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4382	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7666	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	928	usd
CY2023	ebon	Transfer From Prepayments To Property Plant And Equipment TransferFromPrepaymentsToPropertyPlantAndEquipment	34596	usd
CY2022	ebon	Transfer From Prepayments To Property Plant And Equipment TransferFromPrepaymentsToPropertyPlantAndEquipment	4616480	usd
CY2021	ebon	Transfer From Prepayments To Property Plant And Equipment TransferFromPrepaymentsToPropertyPlantAndEquipment	3318477	usd
CY2022	ebon	Liabilities Assumed In Connection With Purchase Of Intangible Assets LiabilitiesAssumedInConnectionWithPurchaseOfIntangibleAssets	5440	usd
CY2021	ebon	Liabilities Assumed In Connection With Purchase Of Intangible Assets LiabilitiesAssumedInConnectionWithPurchaseOfIntangibleAssets	366407	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1801664	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5394251	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3387501	usd
CY2023	ebon	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modification RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModification	320911	usd
CY2022	ebon	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modification RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModification	1485436	usd
CY2023	ebon	Issuance Of Vested Restricted Share Awards IssuanceOfVestedRestrictedShareAwards	98	usd
CY2022	ebon	Issuance Of Vested Restricted Share Awards IssuanceOfVestedRestrictedShareAwards	232	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	241634262	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	251294952	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	239872316	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	88614	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	29039	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	171156	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1197286	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	903125	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	883130	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242920162	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	252227116	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	240926602	usd
CY2023	us-gaap	Subsidiary Of Limited Liability Company Or Limited Partnership Business Purpose SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose	An Australia company
CY2023	ebon	Transfer Of Ownership Description TransferOfOwnershipDescription	100% owned by Ebang International through its subsidiaries
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Reclassification</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no impact on net earnings and financial position.</span></p>
CY2023	ebon	Noncontrolling Interest NoncontrollingInterest	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Non-controlling Interest</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-controlling interest on the consolidated balance sheets is primarily resulted from the consolidation of Hangzhou Dewang, a 51.05% owned subsidiary, and Shanghai Yijiaxin IC Design Co., Ltd. (“Shanghai Yijiaxin”), a wholly-owned subsidiary of Hangzhou Dewang, which became effectively 51.05% owned by the Company. The portion of the income or loss applicable to the non-controlling interest in the subsidiaries are reflected in the consolidated statements of operations and comprehensive income (loss).</p>
CY2023Q4	ebon	Non Controlling Interest Percentage NonControllingInterestPercentage	0.5105	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of estimates and assumptions</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the balance sheet date and revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s consolidated financial statements include the impairment of goodwill and an intangible asset recognized from a business combination, and the purchase price allocation relating to a business combination. Other accounting estimates include, but not limited to, estimates for inventory write-down, share-based compensation, useful lives of long-lived assets, impairment of long-lived assets other than impairment of an intangible asset recognized from a business combination, which is considered as a significant accounting estimate, credit losses, income taxes including valuation allowance for deferred tax assets and implicit interest rate of operating leases. Changes in facts and circumstances may result in revised estimates. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements. </span></p>
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	1285900	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	932164	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1279226	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1835121	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1968316	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-310012	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	496122	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	5835377	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	69361	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1010852	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1209	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	31761	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	126333	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7401430	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5147364	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6557208	usd
CY2023	ebon	Income Tax Expense Benefit Continuing Operation Government Grants IncomeTaxExpenseBenefitContinuingOperationGovernmentGrants	62600	usd
CY2022	ebon	Income Tax Expense Benefit Continuing Operation Government Grants IncomeTaxExpenseBenefitContinuingOperationGovernmentGrants	81911	usd
CY2021	ebon	Income Tax Expense Benefit Continuing Operation Government Grants IncomeTaxExpenseBenefitContinuingOperationGovernmentGrants	434604	usd
CY2023	ebon	Vat Description VATDescription	Revenue is recognized net of value-added taxes (“VAT”). VAT is based on gross sales price and the VAT rate applicable to the Company is 17% for the period from the beginning of 2018 until the end of April 2018, then changed to 16% from May 2018 to the end of March 2019, and changed to 13% since April 2019. Entities that are VAT general taxpayers are allowed to offset qualified input VAT paid to suppliers against their output VAT liabilities. Net VAT balance between input VAT and output VAT is recorded as VAT payable if output VAT is larger than input VAT and is recorded as VAT recoverable if input VAT is larger than output VAT. All of the VAT returns filed by the Company’s subsidiaries in China, have been and remain subject to examination by the tax authorities. Furthermore, the Company’s subsidiaries in China may be qualified to receive a refund on VAT for the excess input VAT after meeting certain prerequisites specified in relevant regulations prescribed by the State Tax Bureau of the PRC.
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	16700000	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	4500000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit	0.50	pure
CY2023	ebon	Statutory Reserve Description StatutoryReserveDescription	Pursuant to the laws applicable to the PRC, PRC entities must make appropriations from after-tax profit to the non-distributable “statutory surplus reserve fund”. Subject to certain cumulative limits, the “statutory surplus reserve fund” requires annual appropriations of 10% of after-tax profit until the aggregated appropriations reach 50% of the registered capital (as determined under accounting principles generally accepted in the PRC (“PRC GAAP”) at each year-end). For foreign-invested enterprises and joint ventures in the PRC, annual appropriations should be made to the “reserve fund”. For foreign-invested enterprises, the annual appropriation for the “reserve fund” cannot be less than 10% of after-tax profits until the aggregated appropriations reach 50% of the registered capital (as determined under PRC GAAP at each year-end).
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of credit risk </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places the cash and cash equivalents with financial institutions with high credit ratings and quality.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company conducts credit evaluations of customers and generally does not require collateral or other security from its customers. The Company establishes an allowance for doubtful accounts primarily based upon various factors surrounding the credit risk of specific customers and general economic conditions. Refer to the current expected credit loss policy.</p>
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	5900000	usd
CY2023	ebon	Total Purchase Consideration TotalPurchaseConsideration	5900000	usd
CY2023	ebon	Cash Payment CashPayment	3100000	usd
CY2023	ebon	Shareholders Of Compass ShareholdersOfCompass	2800000	usd
CY2022Q1	ebon	Exchange Rate Per Share ExchangeRatePerShare	0.7401
CY2022	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	111175	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2299628	usd
CY2023	us-gaap	Taxes And Licenses TaxesAndLicenses	3708247	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	496122	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5611815	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	172402	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	51160	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	496122	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	5835377	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	35758	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	640998	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3890427	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	778085	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	819733	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	739666	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-36772143	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43888242	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4430941	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6275118	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6247333	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5923845	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36772143	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43888242	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4430941	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6275118	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6247333	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5923845	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5013	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6275118	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6247333	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5928858	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.86
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3021794	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	6858185	usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	2075280	usd
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	3523458	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	946514	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3334727	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3523458	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4601637	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4788855	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-304112	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1968316	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-310012	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	981152	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2705446	usd
CY2023	ebon	Effects Of Foreign Exchange Rate EffectsOfForeignExchangeRate	-162914	usd
CY2022	ebon	Effects Of Foreign Exchange Rate EffectsOfForeignExchangeRate	-341049	usd
CY2021	ebon	Effects Of Foreign Exchange Rate EffectsOfForeignExchangeRate	122794	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2075280	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3523458	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4601637	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10064160	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10627535	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	938289	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	953088	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	19632702	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	20125467	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	30635151	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	31706090	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	30436305	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	31266026	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	198846	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	440064	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	340186	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	6482019	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	2233452	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60662533	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	61346776	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27454332	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24797498	usd
CY2023Q4	ebon	Provision For Impairment ProvisionForImpairment	57140	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33151061	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36549278	usd
CY2023	us-gaap	Depreciation Depreciation	3038131	usd
CY2022	us-gaap	Depreciation Depreciation	1822942	usd
CY2021	us-gaap	Depreciation Depreciation	2858406	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	57117	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3109922	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	42344454	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43152499	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15468932	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15523631	usd
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	24545745	usd
CY2022Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	20738130	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2329777	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6890738	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	481728	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8888601	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3399649	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	134407	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	51254	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	51254	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	51254	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	51254	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1990354	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2329777	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2239227	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1928684	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	82265	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	49047	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	53162	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	86991	usd
CY2023Q4	ebon	Payable To Property Plant And Equipment Suppliers PayableToPropertyPlantAndEquipmentSuppliers	4110691	usd
CY2022Q4	ebon	Payable To Property Plant And Equipment Suppliers PayableToPropertyPlantAndEquipmentSuppliers	4565086	usd
CY2023Q4	ebon	Customer Custodial Cash Liabilities CustomerCustodialCashLiabilities	1612075	usd
CY2022Q4	ebon	Customer Custodial Cash Liabilities CustomerCustodialCashLiabilities	3919793	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1707428	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	969490	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9804848	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11519091	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.25	pure
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The applicable tax rate is 8.25% on assessable profits arising in or derived from Hong Kong up to HKD2,000,000 and 16.5% on any part of assessable profits over HKD2,000,000.
CY2023	ebon	Income Tax Effects Description IncomeTaxEffectsDescription	Under the Enterprise Income Tax Laws of the PRC (the “EIT Laws”), domestic enterprises and Foreign Investment Enterprises (the “FIE”) are usually subject to a unified 25% enterprise income tax rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. EIT grants preferential tax treatment to certain High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. For the years ended December 31, 2023, 2022 and 2021, Zhejiang Ebang, Hangzhou Dewang, and Ebang IT were qualified as HNTE and entitled to a preferential income tax rate of 15%.
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	1.50	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	2	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.002	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004	pure
CY2023	ebon	Effect Of Additional Deduction Of Research And Development Expense EffectOfAdditionalDeductionOfResearchAndDevelopmentExpense	0.048	pure
CY2022	ebon	Effect Of Additional Deduction Of Research And Development Expense EffectOfAdditionalDeductionOfResearchAndDevelopmentExpense	0.007	pure
CY2021	ebon	Effect Of Additional Deduction Of Research And Development Expense EffectOfAdditionalDeductionOfResearchAndDevelopmentExpense	-0.351	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.08	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.029	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.609	pure
CY2023	ebon	Effective Income Tax Rate Reconciliation Change In Recovery From Deferred Income Tax Assets EffectiveIncomeTaxRateReconciliationChangeInRecoveryFromDeferredIncomeTaxAssets	0.052	pure
CY2022	ebon	Effective Income Tax Rate Reconciliation Change In Recovery From Deferred Income Tax Assets EffectiveIncomeTaxRateReconciliationChangeInRecoveryFromDeferredIncomeTaxAssets	0.055	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.271	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.28	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.043	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.061	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.457	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.236	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.014	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.026	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.159	pure
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7666	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2466745	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1031461	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-80599	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-2845588	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1031461	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-72933	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-378843	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2007749	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1986464	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30276268	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23052402	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5835385	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	3672475	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38119402	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	28711341	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38119402	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28711341	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1004365	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	74225	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	129174	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	74225	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1133539	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	74225	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1133539	usd
CY2020	ebon	Aggregate Shares Issued AggregateSharesIssued	153333	shares
CY2020	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	4600000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	113333	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	3400000	shares
CY2021Q1	ebon	Exercised Shares Issued ExercisedSharesIssued	56667	shares
CY2021Q1	ebon	Offering Sale Of Units OfferingSaleOfUnits	640000	shares
CY2021Q1	ebon	Exercised Shares Issued ExercisedSharesIssued	320000	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	9600000	shares
CY2021Q1	ebon	Exercised Shares Issued ExercisedSharesIssued	233333	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	7000000	shares
CY2022Q4	ebon	Existing Shares Price Per Share ExistingSharesPricePerShare	0.001
CY2022Q4	ebon	Consolidated Shares ConsolidatedShares	1	shares
CY2022Q4	ebon	Consolidated Shares Price Per Share ConsolidatedSharesPricePerShare	0.03
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	153034	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1064986	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3036689	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	2053911	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1948051	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1177689	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18404	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	35710	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	117118	usd
CY2023	us-gaap	Lease Cost LeaseCost	2072315	usd
CY2022	us-gaap	Lease Cost LeaseCost	1983761	usd
CY2021	us-gaap	Lease Cost LeaseCost	1294807	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2692699	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1559148	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1414151	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1801664	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5394251	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3387501	usd
CY2023Q4	ebon	Operating Lease Rightofuse Asset OperatingLeaseRightofuseAsset	6119535	usd
CY2022Q4	ebon	Operating Lease Rightofuse Asset OperatingLeaseRightofuseAsset	5343608	usd
CY2023Q4	ebon	Operating Lease Rightofuse Assets Related Party OperatingLeaseRightofuseAssetsRelatedParty	31197	usd
CY2022Q4	ebon	Operating Lease Rightofuse Assets Related Party OperatingLeaseRightofuseAssetsRelatedParty	519140	usd
CY2023Q4	ebon	Operating Lease Rightofuse Assets OperatingLeaseRightofuseAssets	6150732	usd
CY2022Q4	ebon	Operating Lease Rightofuse Assets OperatingLeaseRightofuseAssets	5862748	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1764259	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1217604	usd
CY2023Q4	ebon	Operating Lease Liabilities Related Party Current OperatingLeaseLiabilitiesRelatedPartyCurrent	28849	usd
CY2022Q4	ebon	Operating Lease Liabilities Related Party Current OperatingLeaseLiabilitiesRelatedPartyCurrent	283567	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4880844	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5755973	usd
CY2023Q4	ebon	Operating Lease Liabilities Related Party Noncurrent OperatingLeaseLiabilitiesRelatedPartyNoncurrent	2348	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6676300	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7257144	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M2D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06525	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06525	pure
CY2019Q1	ebon	Number Of Units Delivered NumberOfUnitsDelivered	90000	shares
CY2019Q1	ebon	Total Amount Mining Machines TotalAmountMiningMachines	453600000	cny
CY2023Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	241512633	usd
CY2022Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	188481193	usd
CY2023	us-gaap	Revenues Revenues	4855181	usd
CY2022	us-gaap	Revenues Revenues	32328119	usd
CY2021	us-gaap	Revenues Revenues	51450247	usd
CY2023	us-gaap	Revenues Revenues	4855181	usd
CY2022	us-gaap	Revenues Revenues	32328119	usd
CY2021	us-gaap	Revenues Revenues	51450247	usd
CY2019Q1	ebon	Total Approximately Amount Mining Machines TotalApproximatelyAmountMiningMachines	65100000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	41631570	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	51602392	usd
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	1	cny
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	5941	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6700000	usd
CY2022Q2	us-gaap	Assets Net AssetsNet	5941	usd
CY2023Q1	us-gaap	Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest After Disposal DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal	1	pure
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	7524	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2019Q1	ebon	Defendant Paid Amount DefendantPaidAmount	380000000	cny
CY2019Q1	ebon	Defendant Approximately Paid Amount DefendantApproximatelyPaidAmount	54500000	usd
CY2019Q1	ebon	Balance Amount Of Defendant Paid Amount BalanceAmountOfDefendantPaidAmount	73600000	cny
CY2019Q1	ebon	Balance Amount Of Approximately Defendant Paid Amount BalanceAmountOfApproximatelyDefendantPaidAmount	10600000	usd
CY2021Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	73600000	cny
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7400000	cny
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1100000	usd
CY2021Q2	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	2000000	cny
CY2023Q1	ebon	Goods Payment GoodsPayment	2000000	cny
CY2021Q4	us-gaap	Litigation Reserve LitigationReserve	500000	cny
CY2023	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	263322	shares
CY2022	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	24167	shares
CY2023	ebon	Stock Issued During Period Shares Reverse Stock Split StockIssuedDuringPeriodSharesReverseStockSplit	725000	shares
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Auditor Firm AuditorFirmId	206
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	ebon	Operating Lease Liabilities Related Party Noncurrent OperatingLeaseLiabilitiesRelatedPartyNoncurrent		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	ebon	Transfer To Reserve TransferToReserve		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
CY2021	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	ebon	Loss From Cybersecurity Incidence LossFromCybersecurityIncidence		usd
CY2021	ebon	Loss From Cybersecurity Incidence LossFromCybersecurityIncidence		usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables		usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables		usd
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent		usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent		usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2022	ebon	Purchase Of Cryptocurrencies PurchaseOfCryptocurrencies		usd
CY2021	ebon	Purchase Of Cryptocurrencies PurchaseOfCryptocurrencies		usd
CY2022	ebon	Proceeds From Disposal Of Cryptocurrencies ProceedsFromDisposalOfCryptocurrencies		usd
CY2021	ebon	Proceeds From Disposal Of Cryptocurrencies ProceedsFromDisposalOfCryptocurrencies		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities		usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	ebon	Liabilities Assumed In Connection With Purchase Of Intangible Assets LiabilitiesAssumedInConnectionWithPurchaseOfIntangibleAssets		usd
CY2021	ebon	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modification RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModification		usd
CY2021	ebon	Issuance Of Vested Restricted Share Awards IssuanceOfVestedRestrictedShareAwards		usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed		usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023	ebon	Total Purchase Consideration TotalPurchaseConsideration	8000000	aud
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	8000000	aud
CY2022Q1	ebon	Exchange Rate Per Share ExchangeRatePerShare	1.00
CY2023	ebon	Cash Payment CashPayment	4200000	aud
CY2023	ebon	Shareholders Of Compass ShareholdersOfCompass	3800000	aud
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments		usd
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2022Q4	ebon	Provision For Impairment ProvisionForImpairment		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	ebon	Effective Income Tax Rate Reconciliation Change In Recovery From Deferred Income Tax Assets EffectiveIncomeTaxRateReconciliationChangeInRecoveryFromDeferredIncomeTaxAssets		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets		usd
CY2022	ebon	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modification Operating Leases RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModificationOperatingLeases		usd
CY2021	ebon	Remeasurement Of The Lease Liabilities And Rightofuse Assets Due To Lease Modification Operating Leases RemeasurementOfTheLeaseLiabilitiesAndRightofuseAssetsDueToLeaseModificationOperatingLeases		usd
CY2022Q4	ebon	Operating Lease Liabilities Related Party Noncurrent OperatingLeaseLiabilitiesRelatedPartyNoncurrent		usd
CY2023Q1	ebon	Cash Consideration CashConsideration	10000	sgd
CY2023Q4	us-gaap	Litigation Reserve LitigationReserve		cny
CY2022Q4	us-gaap	Litigation Reserve LitigationReserve		cny
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001799290

Files In Submission

Name	View Source	Status
0001213900-24-036625-index-headers.html	Edgar Link	pending
0001213900-24-036625-index.html	Edgar Link	pending
0001213900-24-036625.txt	Edgar Link	pending
0001213900-24-036625-xbrl.zip	Edgar Link	pending
ea0203906-20f_ebang.htm	Edgar Link	pending
ea020390601ex11-1_ebang.htm	Edgar Link	pending
ea020390601ex12-1_ebang.htm	Edgar Link	pending
ea020390601ex13-1_ebang.htm	Edgar Link	pending
ea020390601ex15-1_ebang.htm	Edgar Link	pending
ea020390601ex15-2_ebang.htm	Edgar Link	pending
ea020390601ex15-3_ebang.htm	Edgar Link	pending
ea020390601ex2-5_ebang.htm	Edgar Link	pending
ea020390601ex8-1_ebang.htm	Edgar Link	pending
ea020390601ex97-1_ebang.htm	Edgar Link	pending
ebon-20231231.xsd	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
ea0203906-20f_ebang_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ebon-20231231_cal.xml	Edgar Link	unprocessable
ebon-20231231_def.xml	Edgar Link	unprocessable
ebon-20231231_lab.xml	Edgar Link	unprocessable
ebon-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EBON
Ebang International Holdings Inc. Stock $ebon

2023 Q4 Form 20-F Financial Statement

#000121390024036625 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EBON Ebang International Holdings Inc. Stock $ebon

2023 Q4 Form 20-F Financial Statement

#000121390024036625 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EBON
Ebang International Holdings Inc. Stock $ebon